SAB Biotherapeutics, Inc. (SABSW) Ownership

$0.03

south_east
-$0 (0.4%)
Day's range
$0.03
Day's range
$0.03

SAB Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LMR PARTNERS LLP 02/14/2025 539.59 K $40.63 K   100.00% 5.83%
MORGAN STANLEY 02/14/2025 146.44 K $11.03 K   0.00% 1.58%
YAKIRA CAPITAL MANAGEMENT, INC. 02/13/2025 93.23 K $7.02 K   -14.06% 1.01%
MILLENNIUM MANAGEMENT LLC 02/14/2025 62.50 K $4.71 K   0.00% 0.68%
HB WEALTH MANAGEMENT, LLC 01/15/2025 50.00 K $3.87 K   -83.87% 0.54%
WALLEYE TRADING LLC 02/13/2025 38.76 K $2.92 K   150.00% 0.42%
WOLVERINE ASSET MANAGEMENT LLC 02/03/2025 8.66 K $651   -44.23% 0.09%
UBS GROUP AG 02/14/2025 1.63 K $122   100.00% 0.02%
NEWEDGE ADVISORS, LLC 02/13/2025 1.07 K $80   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 48 $4   0.00% 0.00%
LMR PARTNERS LLP 02/14/2025 0 $0   -100.00% 0.00%
WALLEYE CAPITAL LLC 02/13/2025 0 $0   -100.00% 0.00%

SAB Biotherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 10 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:

LMR Partners LLP: 539,588

MORGAN STANLEY: 146,439

Yakira Capital Management, Inc.: 93,230

HB Wealth Management, LLC: 50,001

Walleye Trading LLC: 38,763

WOLVERINE ASSET MANAGEMENT LLC: 8,655

9.50% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 879.43 K shares in the last 24 months. This purchase volume represents approximately $26.38 K in transactions.